Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test
about
Issues Related to the Updated 2014 Korean Guidelines for TuberculosisPrevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysisEvolution of drug resistance in tuberculosis: recent progress and implications for diagnosis and therapyTranslating genomics research into control of tuberculosis: lessons learned and future prospectsSecond line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspectiveSoluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responsesThe Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant TuberculosisTackling tuberculosis: Insights from an international TB Summit in LondonMultiplex detection of bacteria on an integrated centrifugal disk using bead-beating lysis and loop-mediated amplificationCan China achieve the WHO global targets for TB control by 2035?Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-careWhat happens after a negative test for tuberculosis? Evaluating adherence to TB diagnostic algorithms in South African Primary Health Clinics.Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries.Construction of a virtual Mycobacterium tuberculosis consensus genome and its application to data from a next generation sequencer.Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, ZambiaUsefulness of sputum induction with hypertonic saline in a real clinical practice for bacteriological yields of active pulmonary tuberculosisMolecular diagnosis of central nervous system opportunistic infections and mortality in HIV-infected adults in Central ChinaComparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis.Serological diagnostic assays for HIV-associated tuberculosis in sub-Saharan Africa?Availability and use of molecular microbiological and immunological tests for the diagnosis of tuberculosis in europeComprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014.Tuberculosis in tropical areas and immigrants.Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study.Prognostic value of a quantitative analysis of lipoarabinomannan in urine from patients with HIV-associated tuberculosis.Experiences in anti-tuberculosis treatment in patients with multiple previous treatments and its impact on drug resistant tuberculosis epidemicsAssessing the quality of tuberculosis evaluation for children with prolonged cough presenting to routine community health care settings in rural UgandaTime to culture positivity and sputum smear microscopy during tuberculosis therapy.Development of a POC test for TB based on multiple immunodominant epitopes of M. tuberculosis specific cell-wall proteins.Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review.HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays.Video Q&A: rapid urine LAM test for HIV-associated TB--potential to reduce deaths? An interview with Stephen LawnDetermine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studiesDiagnostic accuracy of the Xpert MTB/RIF assay for extrapulmonary and pulmonary tuberculosis when testing non-respiratory samples: a systematic review.Modeling the implementation of universal coverage for HIV treatment as prevention and its impact on the HIV epidemic.Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled TrialOptimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysisHigh mortality in adults hospitalized for active tuberculosis in a low HIV prevalence setting.Detection of Mycobacterium tuberculosis DNA on the oral mucosa of tuberculosis patients.Rapid diagnosis of pleural tuberculosis by Xpert MTB/RIF assay using pleural biopsy and pleural fluid specimens
P2860
Q26771907-A0445AA6-9E63-489B-B01D-62BC24703BA5Q26798435-E67ABD4F-8071-4200-A35E-F3E5967A0B14Q27016579-1DCC0954-87B3-4CFF-B8E4-05AE0C50E2B8Q27023437-ADEDA6E4-1FA8-4097-ADA2-B1488199419CQ28074085-4F39D20F-F16D-452A-BFCA-DD8480B68C53Q28534690-1A5D15F7-89D5-4855-80EA-9600B95456F3Q28546035-E1259C5E-138A-4A97-9BF2-54F0D8A48911Q28602294-ADFE646F-490A-419E-9E4B-D1A46895E79CQ29994833-C4F7EF7C-C616-4D2C-BE9A-E87B05A7EFACQ30062075-AB095F8D-4373-4B41-90D4-E837D555C49DQ30397647-BAD31662-09F8-4A19-BC79-195B97A1ECEEQ30488634-277E5DE8-1BD0-469A-8FC7-7737FAE62CDFQ30566518-24D15E53-56D4-484D-AF76-EC29737C2D1BQ30934049-6A0A41B8-E8D9-4C98-9414-34CA8945A986Q33593613-953732B9-A364-4AC6-BB1A-6BD3A43FBAD0Q33612348-C3798839-29B0-4D19-AAF1-E9E5AC37543CQ33629698-A2EF0EB4-46D8-41C2-8B3D-215995E59344Q33703611-E51E6CBD-AC80-465D-9748-5A9C49DBE820Q33743476-4B0015C5-4156-4FD3-90AB-9940F96BD87CQ33748685-DB2CDF01-4E68-41C9-8E57-C3A744F9CFD8Q33777533-92F1F817-34AB-4059-BE4E-AB7B325C3FA3Q33778365-70230F02-EEDF-462C-8530-E4D8C2C5AA04Q33816191-B3B2CDF8-A02C-44DB-A353-707CFCE05BADQ33975232-906128A1-9B8F-42C0-BABC-B77D88C3CACBQ34068034-03F61607-FA1F-453E-A5AF-87701D2C5CCDQ34110262-2F15C716-A46C-4664-8AA3-E3BD626A8E9FQ34110301-A6553980-BB21-42BC-A5D0-1A1505E24B61Q34231783-861CFBF9-3400-40E1-B970-3EE93C3631E9Q34455442-4DFE44D0-1E70-4DB7-B762-3FBAE68B33FDQ34509326-2B16B721-8EF9-47FA-914D-59EBCFC48915Q34798215-A1096839-23EA-499C-B461-F0D4AF26ED88Q34978276-B61EB4D8-D62C-4CCF-9B3E-2713EA4F3AFAQ34984563-5C66D31C-38E4-40A0-B3FB-6B52C3DC1E0BQ34993280-8C69D010-7036-4647-9308-3176AC1AFC06Q35017694-64CA2CA2-C452-4AF4-AFCA-056908FEDF16Q35071965-BA11035C-FABF-453F-809C-6DE70E2010D0Q35075418-F55C4079-6AC8-4D82-8B49-FB636B796B30Q35124067-BF72FEF7-FEB8-4CE2-A78C-33A13090D9B0Q35133974-493876C6-F66E-465A-B7FE-8D94D427EE9DQ35160500-5278D082-DE0F-4FC4-9F17-404DA11AB545
P2860
Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Advances in tuberculosis diagn ...... pects for a point-of-care test
@en
type
label
Advances in tuberculosis diagn ...... pects for a point-of-care test
@en
prefLabel
Advances in tuberculosis diagn ...... pects for a point-of-care test
@en
P2093
P2860
P50
P1476
Advances in tuberculosis diagn ...... pects for a point-of-care test
@en
P2093
Amy Piatek
Ben J Marais
Heather Alexander
Marco Schito
P2860
P304
P356
10.1016/S1473-3099(13)70008-2
P50
P577
2013-03-24T00:00:00Z